These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8298479)

  • 21. Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia.
    Fujisaki T; Otsuka T; Gondo H; Okamura T; Niho Y; Ohhinata A; Abe F
    Int Immunopharmacol; 2003 Jun; 3(6):901-7. PubMed ID: 12781706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion.
    Jootar S; Pornprasertsud N; Petvises S; Rerkamnuaychoke B; Disthabanchong S; Pakakasama S; Ungkanont A; Hongeng S
    Leuk Res; 2006 Dec; 30(12):1493-8. PubMed ID: 16839603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
    Einat M; Lishner M; Amiel A; Nagler A; Yarkorli S; Rudi A; Kashman Y; Markel D; Fabian I
    Exp Hematol; 1995 Dec; 23(14):1439-44. PubMed ID: 8542929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; van der Hem KG; Odding JH; Dräger AM; Ossenkoppele GJ
    Br J Cancer; 1999 Mar; 79(9-10):1406-12. PubMed ID: 10188883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe functional alterations in vitro in CD34(+) cell subpopulations from patients with chronic myeloid leukemia.
    Chávez-González A; Rosas-Cabral A; Vela-Ojeda J; González JC; Mayani H
    Leuk Res; 2004 Jun; 28(6):639-47. PubMed ID: 15120942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures.
    Chávez-González A; Ayala-Sánchez M; Sánchez-Valle E; Ruiz-Sánchez E; Arana-Trejo RM; Vela-Ojeda J; Mayani H
    Leuk Res; 2006 Mar; 30(3):286-95. PubMed ID: 16111748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blast colony-forming cell binding from CML bone marrow, or blood, on stromal layers pretreated with G-CSF or SCF.
    Gidáli J; László E; Halm G; Fehér I
    Cell Prolif; 2002 Feb; 35(1):1-7. PubMed ID: 11856174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
    Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunosuppressive therapy in bone marrow aplasia: the stroma functions normally to support hematopoiesis.
    Novitzky N; Jacobs P
    Exp Hematol; 1995 Dec; 23(14):1472-7. PubMed ID: 8542933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual Ph-negative stem cells in chronic myeloid leukemia--sometimes or always?
    Goldman JM; O'Brien SG
    Stem Cells; 1993 Oct; 11 Suppl 3():4-7. PubMed ID: 8298477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid decline of clonogenic hemopoietic progenitors in semisolid cultures of bone marrow samples derived from patients with chronic myeloid leukemia.
    Wandl U; Messner HA
    Int J Cell Cloning; 1989 Sep; 7(5):314-21. PubMed ID: 2768845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Instability of BCR-ABL gene in primary and cultured chronic myeloid leukemia stem cells.
    Jiang X; Saw KM; Eaves A; Eaves C
    J Natl Cancer Inst; 2007 May; 99(9):680-93. PubMed ID: 17470736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
    Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A model of the interclonal interactions in chronic myeloleukemia].
    Mamaev NN; Gushchin VA
    Eksp Onkol; 1989; 11(3):22-5. PubMed ID: 2752939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous stem cell transplantation for patients with chronic myeloid leukemia. The Argentine Group of Bone Marrow Transplantation (GATMO) experience.
    Koziner B; Dengra C; Lucero G; Klein G; Cánepa C; Milovic V; Milone G; Robinson A; Cerutti I; Saporito G; Kusminsky G; Milone J; Bordone J; Lastiri F;
    Cancer; 2002 Dec; 95(11):2339-45. PubMed ID: 12436440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors.
    Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G
    Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Ph-negative abnormal clones emerging during imatinib therapy.
    Abruzzese E; Gozzetti A; Galimberti S; Trawinska MM; Caravita T; Siniscalchi A; Cervetti G; Mauriello A; Coletta AM; De Fabritiis P
    Cancer; 2007 Jun; 109(12):2466-72. PubMed ID: 17503437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphological and functional characteristics of short-term and long-term bone marrow cultures in chronic myelogenous leukemia.
    Budak-Alpdoğan T; Alpdoğan O; Akoğlu T
    Am J Hematol; 1999 Dec; 62(4):212-20. PubMed ID: 10589076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.